Purchase Order W81K0023P0001
Award Date
10/1/23
Potential Completion Date
9/30/28
Potential Value
$535K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Awardee
Immucor Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
6505 - Drugs And Biologicals
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
El Paso, TX 79918, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
4
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed price purchase order for $480,136.70 was awarded by the Defense Health Agency to Immucor Inc. to establish a cost-per-test arrangement in support of blood bank automated analyzers and testing for the Department of Pathology and Area Laboratory Services at William Beaumont Army Medical Center, Fort Bliss, Texas. The original solicitation requested testing groups including ABO/Rh, antibody screen, antibody identification, and direct antiglobulin test. Under this contract, Immucor...
This firm fixed-price purchase order contract was awarded by the Medical Command (MEDCOM) component of the Department of Defense to Immucor Inc., a manufacturer of in vitro diagnostic products and reagents. The $187,452.19 contract is for the delivery of molecular BeadChip reagents compatible with the BioArray Array Imaging System (AIS 400) and BioArray Solutions Information System Software (BASIS) to support blood typing and screening operations at the Brooke Army Medical Center in Fort Sam...
The Department of the Army Medical Command awarded a firm fixed-price purchase order contract to Immucor Inc., a for-profit manufacturer of goods, for the supply of reagents and the use of the Echo Lumena analyzer for blood bank operations. The base period of performance is from October 1, 2019, to September 30, 2020, with a potential total value of $905,144.61. The contract was awarded without a set-aside designation and is set to continue through September 30, 2022. Immucor is a leading...
This is a delivery order contract awarded by the Department of the Air Force Air Education and Training Command to Immucor Inc., a for-profit manufacturer, for the lease of blood typing analyzers with reagents. The contract has a total potential value of $117,340.43 and a completion date of September 30, 2019. This award is not associated with a set-aside program. Immucor is a leading provider of automated instrument-reagent systems and consumables for blood transfusion and transplantation...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer of in vitro diagnostic medical products, specifically blood typing, compatibility testing, and antibody screening reagents and consumables. The $137,483.05 contract has an ultimate completion date of December 31, 2027 and does not utilize any set-aside designations. Immucor is a key supplier of specialized blood banking technologies and supplies to federal healthcare...
Immucor Inc. was awarded a firm fixed price blanket purchase agreement (BPA) call contract by the Defense Health Agency on October 18, 2023. The contract has a potential value of $18,287.55 and requires delivery of Rapid Screen, Complement Control Cells, Panocell 20, and Immucor reagents by October 17, 2024 at Fort Belvoir, Virginia. No set-aside designation was used for this award to support the Defense Health Agency's medical products procurement programs. Immucor Inc. will serve as the...
This federal contract was awarded by the Defense Health Agency (DHA) to Immucor Inc., a for-profit manufacturer of in vitro diagnostic products for blood transfusion and transplantation testing. The contract, valued at $209,111.24, is for the delivery of CLIN reagents and supplies. It is a firm fixed-price Blanket Purchase Agreement (BPA) call order with a completion date of March 13, 2019. Immucor has a history of providing specialized reagents, blood analyzers, testing equipment, and related...
This federal contract award to Immucor Inc. is for the provision of blood bank typing equipment to the U.S. Air Force's Air Education and Training Command (AETC). The contract has a ceiling value of $116,810.39 and a completion date of March 10, 2025. It is a firm fixed-price delivery order contract and does not have a set-aside designation. Immucor is a leading provider of automated instrument-reagent systems and consumables for blood transfusion and transplantation compatibility testing. The...
This is a firm-fixed price supply contract awarded by the Defense Health Agency (DHA) to Immucor Inc., a for-profit manufacturer of in vitro diagnostic medical products. The contract, valued at $1,016,206.99, is for the delivery of consumable reagents used for blood typing, antibody screening, and identifying compatible blood products for transfusion. The contract has a base period of one year from October 1, 2023 to September 30, 2024, with four one-year option periods. The original...
This is a firm fixed-price purchase order awarded by the Defense Health Agency to Immucor Inc., a for-profit manufacturer, for the delivery of medical supplies such as fetal blood screen kits, blood cells, and PanoCell products. The potential value of the contract is $216,898.69, with a performance period through April 24, 2023. The contract does not have a set-aside designation. Immucor has previously been awarded federal contracts to provide blood banking supplies, reagents, and testing...